Apollo Hospitals Enterprise announced its financial results for the quarter ended December 31, 2024.
On February 11, 2025, Apollo Hospitals share price opened at ₹6,799.90, up from its previous close of ₹6,761.25. However, at 9:41 AM, the share price of Apollo Hospitals was trading at ₹6,531.40, down by 3.40% on the NSE.
The company’s consolidated revenues for Q3 FY25 surged 14% YoY, reaching ₹5,527 crore, compared to the same quarter last year. Consolidated EBITDA grew 24% YoY to ₹762 crore, reflecting robust operational efficiency.
Profit After Tax (PAT) for the quarter recorded a 52% YoY growth, standing at ₹372 crore.
For the nine months ending December 2024, consolidated revenues grew 15% YoY to ₹16,202 crore. YTD PAT stood at ₹1,056 crore, a 64% YoY increase from ₹645 crore in YTD FY24.
Apollo Hospitals achieved a significant milestone in cardiac care, completing over 1,000 robotic cardiac surgeries across Bangalore and Chennai.
The company also partnered with Microsoft and aims to leverage AI and digital innovation to focus on disease progression and genomics.
The company stated that they are on track to add 3,512 beds over the next 3-4 years, starting FY26, further strengthening its healthcare network.
The company’s Board declared an interim dividend of ₹9 per share (180% of face value ₹5). The record date is February 15, 2025, and payment will be completed by February 28, 2025.
Commenting on the performance, the Chairman of Apollo Hospitals Enterprise Ltd, Dr Prathap C Reddy, said, “At Apollo Hospitals, we recognise the rising burden of cancer and launched the Unify to Notify campaign towards classifying cancer as a notifiable disease. Our pursuit of enhancing our clinical excellence continues with landmark surgeries and treatments at our hospitals across India. Apollo Hospitals, Chennai achieved a remarkable benchmark in cardiac care by completing 500 robotic cardiac surgeries.”
He further added, “Apollo Hospitals, Bangalore performed a robotic knee replacement surgery on a 17-year-old boy, the youngest reported case in the world, who was struggling with severe Avascular Necrosis. As we look ahead, we are confident about our plans to create a sustainable impact and value to ‘Heal in India’ and ‘Heal by India’ with world-class healthcare and cutting-edge innovation not just for India but for the world.”
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 11, 2025, 9:50 AM IST
Nikitha Devi
Nikitha is a content creator with 6+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
